Cargando…

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats

Qiliqiangxin capsule (QLC), a natural herb recipe with therapeutic effect from China, has been widely used in clinical practice for attenuating cardiac remodeling induced by myocardial infarction (MI). However, the pharmacological mechanism of QLC on cardiac remodeling after MI is not entirely clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huiyang, Lou, Lixia, Zhang, Dongmei, Zhao, Yizhou, Zhao, Jing, Li, Chunhong, Huang, Ya, Liu, Keke, Zhao, Mingjing, Wu, Aiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437749/
https://www.ncbi.nlm.nih.gov/pubmed/31001355
http://dx.doi.org/10.1155/2019/7528214
_version_ 1783406986530914304
author Chen, Huiyang
Lou, Lixia
Zhang, Dongmei
Zhao, Yizhou
Zhao, Jing
Li, Chunhong
Huang, Ya
Liu, Keke
Zhao, Mingjing
Wu, Aiming
author_facet Chen, Huiyang
Lou, Lixia
Zhang, Dongmei
Zhao, Yizhou
Zhao, Jing
Li, Chunhong
Huang, Ya
Liu, Keke
Zhao, Mingjing
Wu, Aiming
author_sort Chen, Huiyang
collection PubMed
description Qiliqiangxin capsule (QLC), a natural herb recipe with therapeutic effect from China, has been widely used in clinical practice for attenuating cardiac remodeling induced by myocardial infarction (MI). However, the pharmacological mechanism of QLC on cardiac remodeling after MI is not entirely clear. The present study aims to investigate the effectiveness and mechanisms of QLC on cardiac remodeling induced by MI in rats. The animal model was established by permanently ligating the left anterior descending coronary artery in rats. Subsequently, rats with successful ligation were randomly divided into model group, captopril group, and QLC group. And the control group was operated upon in parallel except ligation, namely, the sham group. All rats were treated through the intragastric administration once a day for 4 weeks. Cardiac hemodynamics was measured after treatment. Then, the left ventricular mass index (LVMI) was examined. The pathological changes were observed by HE staining. The collagen volume fraction (CVF) was detected by Masson trichrome staining. The apoptosis index was obtained by TUNEL fluorescent staining. The miR-133a and mRNA of TGF-β1, CTGF, Caspase9, and Caspase3 were examined by real-time PCR. The protein expressions of TGF-β1, CTGF, Caspase9, Caspase3, and cleaved-Caspase3 were tested by Western blot. Compared with the model group, QLC partially improved cardiac hemodynamics and decreased LVMI. miR-133a was significantly increased in QLC group. In addition, QLC declined CVF by downregulating TGF-β1 rather than CTGF. Meanwhile, QLC decreased the apoptosis index by attenuating Caspase9, Caspase3, and cleaved-Caspase3. This study suggested that QLC could improve cardiac function and partially attenuate cardiac remodeling by attenuating fibrosis and decreasing apoptosis, which might be partially related to miR-133a, TGF-β1, Caspase9, and Caspase3.
format Online
Article
Text
id pubmed-6437749
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64377492019-04-18 Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats Chen, Huiyang Lou, Lixia Zhang, Dongmei Zhao, Yizhou Zhao, Jing Li, Chunhong Huang, Ya Liu, Keke Zhao, Mingjing Wu, Aiming Evid Based Complement Alternat Med Research Article Qiliqiangxin capsule (QLC), a natural herb recipe with therapeutic effect from China, has been widely used in clinical practice for attenuating cardiac remodeling induced by myocardial infarction (MI). However, the pharmacological mechanism of QLC on cardiac remodeling after MI is not entirely clear. The present study aims to investigate the effectiveness and mechanisms of QLC on cardiac remodeling induced by MI in rats. The animal model was established by permanently ligating the left anterior descending coronary artery in rats. Subsequently, rats with successful ligation were randomly divided into model group, captopril group, and QLC group. And the control group was operated upon in parallel except ligation, namely, the sham group. All rats were treated through the intragastric administration once a day for 4 weeks. Cardiac hemodynamics was measured after treatment. Then, the left ventricular mass index (LVMI) was examined. The pathological changes were observed by HE staining. The collagen volume fraction (CVF) was detected by Masson trichrome staining. The apoptosis index was obtained by TUNEL fluorescent staining. The miR-133a and mRNA of TGF-β1, CTGF, Caspase9, and Caspase3 were examined by real-time PCR. The protein expressions of TGF-β1, CTGF, Caspase9, Caspase3, and cleaved-Caspase3 were tested by Western blot. Compared with the model group, QLC partially improved cardiac hemodynamics and decreased LVMI. miR-133a was significantly increased in QLC group. In addition, QLC declined CVF by downregulating TGF-β1 rather than CTGF. Meanwhile, QLC decreased the apoptosis index by attenuating Caspase9, Caspase3, and cleaved-Caspase3. This study suggested that QLC could improve cardiac function and partially attenuate cardiac remodeling by attenuating fibrosis and decreasing apoptosis, which might be partially related to miR-133a, TGF-β1, Caspase9, and Caspase3. Hindawi 2019-03-14 /pmc/articles/PMC6437749/ /pubmed/31001355 http://dx.doi.org/10.1155/2019/7528214 Text en Copyright © 2019 Huiyang Chen et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chen, Huiyang
Lou, Lixia
Zhang, Dongmei
Zhao, Yizhou
Zhao, Jing
Li, Chunhong
Huang, Ya
Liu, Keke
Zhao, Mingjing
Wu, Aiming
Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title_full Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title_fullStr Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title_full_unstemmed Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title_short Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
title_sort qiliqiangxin capsule improves cardiac function and attenuates cardiac remodeling by upregulating mir-133a after myocardial infarction in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437749/
https://www.ncbi.nlm.nih.gov/pubmed/31001355
http://dx.doi.org/10.1155/2019/7528214
work_keys_str_mv AT chenhuiyang qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT loulixia qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT zhangdongmei qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT zhaoyizhou qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT zhaojing qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT lichunhong qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT huangya qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT liukeke qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT zhaomingjing qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats
AT wuaiming qiliqiangxincapsuleimprovescardiacfunctionandattenuatescardiacremodelingbyupregulatingmir133aaftermyocardialinfarctioninrats